Advances in 211At production at Texas A&M University

Yennello S.J.; McIntosh L.A; Burns J.D.; Tereshatov E.E.; Tabacaru G.; McCann L.; Schultz S.; Lofton K.; Abbott A.; Avila G.; Berko M.; Engelthaler E.; Hagel K.; Hannaman A.; Harvey B.; Hood A.; McCarthy M.; McIntosh A.B.; Sorensen M.; Tobin Z; Vonder Haar A.

doi:10.1051/epjconf/202125203002

EPJ Web of Conferences (Jan 2021)

Advances in 211At production at Texas A&M University

Yennello S.J.,
McIntosh L.A,
Burns J.D.,
Tereshatov E.E.,
Tabacaru G.,
McCann L.,
Schultz S.,
Lofton K.,
Abbott A.,
Avila G.,
Berko M.,
Engelthaler E.,
Hagel K.,
Hannaman A.,
Harvey B.,
Hood A.,
McCarthy M.,
McIntosh A.B.,
Sorensen M.,
Tobin Z,
Vonder Haar A.

Affiliations

Yennello S.J.
McIntosh L.A: Cyclotron Institute, Texas A&M University, College Station
Burns J.D.: Nuclear Engineering and Science Center, Texas A&M University, College Station
Tereshatov E.E.: Cyclotron Institute, Texas A&M University, College Station
Tabacaru G.: Cyclotron Institute, Texas A&M University, College Station
McCann L.
Schultz S.
Lofton K.
Abbott A.: Cyclotron Institute, Texas A&M University, College Station
Avila G.: Cyclotron Institute, Texas A&M University, College Station
Berko M.
Engelthaler E.
Hagel K.: Cyclotron Institute, Texas A&M University, College Station
Hannaman A.: Cyclotron Institute, Texas A&M University, College Station
Harvey B.: Cyclotron Institute, Texas A&M University, College Station
Hood A.: Cyclotron Institute, Texas A&M University, College Station
McCarthy M.: Cyclotron Institute, Texas A&M University, College Station
McIntosh A.B.: Cyclotron Institute, Texas A&M University, College Station
Sorensen M.: Cyclotron Institute, Texas A&M University, College Station
Tobin Z: Cyclotron Institute, Texas A&M University, College Station
Vonder Haar A.: Cyclotron Institute, Texas A&M University, College Station

DOI: https://doi.org/10.1051/epjconf/202125203002
Journal volume & issue: Vol. 252
p. 03002

Abstract

Read online

Alpha emitting radionuclides with medically relevant half-lives are interesting for treatment of tumors and other diseases because they deposit large amounts of energy close to the location of the radioisotope. Researchers at the Cyclotron Institute at Texas A&M University are developing a program to produce 211At, an alpha emitter with a medically relevant half-life. The properties of 211At make it a great candidate for targeted alpha therapy for cancer due to its short half-life (7.2 h). Astatine-211 has now been produced multiple times and reliability of this process is being improved.

Published in EPJ Web of Conferences

ISSN: 2100-014X (Online)
Publisher: EDP Sciences
Country of publisher: France
LCC subjects: Science: Physics
Website: http://www.epj-conferences.org/

About the journal